glp-1 post bariatric surgery Differences on secretion and action between and Altered glucose metabolism after bariatric
Description
Insulin and sulfonylureas require dose adjustment to prevent hypoglycemia

Current evidence does not yet define a clear therapeutic role for GLP-1RAs, highlighting the need for further research on optimal dosing and treatment duration

It is of interest that an intraduodenal meal increases plasma PYY even before nutrients reach the PYY-containing cells in the ileum or colon

Individuals with low gut microbiota abundance have been found to be susceptible to obesity, insulin resistance and dyslipidemia (le Chatelier et al., 2013)

doi: 10.1111/dom.12693 133 ItohYKawamataYHaradaMKobayashiMFujiiRFukusumiSet al

Effects of semaglutide and empagliflozin on inflammatory markers in patients with type 2 diabetes
